Pathophysiology and management of monoclonal gammopathy of renal significance. (2019)
Attributed to:
Randomised trials in cardiovascular and metabolic disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1182/bloodadvances.2019031914
PubMed Identifier: 31409583
Publication URI: http://europepmc.org/abstract/MED/31409583
Type: Journal Article/Review
Volume: 3
Parent Publication: Blood advances
Issue: 15
ISSN: 2473-9529